Skip to content or view screen version

Hidden Article

This posting has been hidden because it breaches the Indymedia UK (IMC UK) Editorial Guidelines.

IMC UK is an interactive site offering inclusive participation. All postings to the open publishing newswire are the responsibility of the individual authors and not of IMC UK. Although IMC UK volunteers attempt to ensure accuracy of the newswire, they take no responsibility legal or otherwise for the contents of the open publishing site. Mention of external web sites or services is for information purposes only and constitutes neither an endorsement nor a recommendation.

Obama has lost "Single Payer."

Stephen Hemsley | 18.08.2009 22:31

He should go back to teaching

Stephen Hemsley's gloat
Stephen Hemsley's gloat


Obama is too weak to be President.

He’ll be a one term president if he doesn’t “ pull up his pants.”

He’s got a slick way of talking and walking but that’s about all.

What he says, he says like a professor, with great knowledge but without any force or consequence except in the debating arena.

He hasn’t got the steel to take on the heavyweights in Health or The Middle East.

Next thing you know he’ll be handing over The West Bank to Israel for a slave-labour colony and attacking Iran having spent his first year talking about settlements.

Obama indicated this weekend that he is not strong enough to force through a single payer health insurance plan.

The Health insurance industry has forced him to back down because they knew he was weak when he cut a secret deal with them.

The Huffington Post has obtained a memo that shows the White House cut a secret deal with PhRMA, to oppose any congressional efforts to use the government’s leverage to bargain for lower drug prices or import drugs from Canada and also agreed not to pursue Medicare rebates or shift some drugs from Medicare Part B to Medicare Part D, which would cost Big Pharma billions in reduced reimbursements.

In exchange, PhRMA, the Pharmaceutical Researchers and Manufacturers Association, the lobbying association for the drug companies, agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years.

Stephen Hemsley